SEO URLwww.firestrike.ai/deals/organon-sun-pharma-acquisition-2026-7
acquisitionAnnounced · Jan 19, 2026pharmaceuticalsSource · Community DiscussionsArticle · Expectations
Sun Pharma acquires Organon
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$10B
Target
Organon
NYSE: OGN · Jersey City, New Jersey
Acquirer
Sun Pharma
Full Acquisition
Status
Pending
Sun Pharma agreed to acquire Organon. Reported deal value: $10B. Status: Pending. Sector: pharmaceuticals. Target headquarters context: Jersey City, New Jersey, United States.
This page summarizes publicly available information about the transaction as of 2026-01-19. Figures and status may change as filings and press coverage update.
Sun Pharma , India biggest drugmaker, is reportedly looking to buy US-based Organon for $ 10 billion -a move that would mark the largest global pharma takeover by an India n company
Deal timeline
Announced
Jan 19, 2026 · newsbytesapp.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in pharmaceuticals with a reported deal value of $10B. Figures and status may change as sources update.
Sources: newsbytesapp.com · Primary article · FireStrike proprietary index